Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Pharmacoepidemiology and Drug Safety|March 26, 2018
Methodology for computing the burden of disease of adverse events following immunizationScott A McDonald, Danielle Nijsten, Kaatje Bollaerts, et al.
Thyroid : Official Journal of the American Thyroid Association|March 15, 2014
Thyroid cancer incidence in the vicinity of nuclear sites in Belgium, 2000-2008Kaatje Bollaerts, Sébastien Fierens, Lodewijk Van Bladel, et al.
BMC Infectious Diseases|May 20, 2017
Estimation of the burden of varicella in Europe before the introduction of universal childhood immunizationMargarita Riera-Montes, Kaatje Bollaerts, Ulrich Heininger, et al.
Cancer Epidemiology|December 6, 2014
Thyroid cancer incidence around the Belgian nuclear sites: surrogate exposure modellingKaatje Bollaerts, Michel Sonck, Koen Simons, et al.
Plos One|May 26, 2017
Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studiesMyint Tin Tin Htar, Anke L Stuurman, Germano Ferreira, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 6, 2016
Childhood leukaemia near nuclear sites in Belgium, 2002-2008Kaatje Bollaerts, Koen Simons, Lodewijk Van Bladel, et al.
Human Vaccines & Immunotherapeutics|March 20, 2018
Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccineKarl-Ulrich Petry, Kaatje Bollaerts, Paolo Bonanni, et al.
Vaccines|October 28, 2025
Precautionary Health Behaviours as Potential Confounders in COVID-19 Vaccine Effectiveness StudiesChloé Wyndham-Thomas, Leonie de Munter, Kok Yew Ngew, et al.
Vaccine|November 4, 2019
ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modellingKaatje Bollaerts, Edouard Ledent, Tom de Smedt, et al.
Vaccine|November 4, 2019
ADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databasesKaatje Bollaerts, Tom de Smedt, Chris McGee, et al.
Pageof 5